市場調查報告書

皮膚病市場:2019-2025

Dermatological Therapeutics Market 2019-2025

出版商 Orion Market Research Pvt Ltd 商品編碼 949498
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
皮膚病市場:2019-2025 Dermatological Therapeutics Market 2019-2025
出版日期: 2020年06月01日內容資訊: 英文
簡介

在預測期內,預計全球皮膚病藥物市場將顯著增長。市場增長的主要動力是全球老年人口的增加。隨著年齡的增長,與皮膚有關的疾病很可能是由於生活方式改變,皮膚強度和彈性降低以及皮脂腺分泌減少等因素引起的。皮膚疾病的發生率不斷上升,人們對與皮膚相關疾病的某些治療方法的發展,病因學和可用性的認識提高,這是全球皮膚病藥物市場增長的一些關鍵驅動力..但是,價格上漲和公眾意識的缺乏,尤其是在新興經濟體,是預測期內市場增長障礙的一部分。

本報告調查和分析了全球皮膚病藥物市場,市場概況,影響市場增長的因素,市場規模和預測,按細分市場的分析,按地區/國家進行的市場分析,競爭情況。我們提供有關此類事情的系統信息。

內容

第1章報告概述

第2章市場概述和討論

  • 調查範圍
  • 分析師見解和當前市場趨勢
  • 規則與規定

第3章競爭情況

  • 主要策略分析
  • 主要公司分析
    • Amgen Inc.
    • 諾華國際公司
    • Abbvie Inc.
    • 艾爾建(Allergan)PLC

第4章市場決定因素

  • 主持人
  • 抑制因子
  • 機會

第5章市場細分

  • 全球皮膚科藥物市場按藥物類別
    • 抗感染藥
    • 皮質類固醇
    • 鈣調神經磷酸□抑製劑
    • 類視黃醇
    • 其他
  • 全球皮膚科市場應用
    • 脫髮
    • 皰疹
    • 牛皮癬
    • 清酒
    • 特應性皮炎
    • 轉移性黑色素瘤
    • 其他

第6章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 其他地區

第7章公司簡介

  • AbbVie Inc.
  • Aclaris Therapeutics, Inc.
  • Allergan PLC
  • Almirall SA
  • Amgen Inc.
  • Aurobindo Pharma Ltd.
  • Bausch Health Companies Inc.
  • Cipher Pharmaceuticals Inc.
  • Eli Lilly & Co.
  • Galderma SA
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Ltd.
  • Johnson & Johnson Services Inc.
  • LEO Pharma A/S
  • Novartis International AG
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
目錄
Product Code: OMR2021817

Global Dermatological Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Anti-infectives, Corticosteroids, Calcineurin Inhibitors, Retinoids, and Others), By Applications (Alopecia, Herpes, Psoriasis, Rosacea, Atopic Dermatitis, Metastatic Malignant Melanoma, and Others), and Forecast 2019-2025

The global psoriasis market is estimated to grow significantly during the forecast period. The primary factors that drive the growth of the market include the rising geriatric population across the globe. As people age, they are more prone to developing skin-related disorders due to factors such as lifestyle changes, reduced skin strength and elasticity, and lower sebaceous gland secretions. The increasedoccurrence of dermatological illnesses and increased awareness regarding the development of the skin-related disease, etiology, and availability of several therapies are some of the key factors to drive the globaldermatological therapeutics market growth. However, lack of awareness among the peoples especially in emerging economies along with the higher prices is some of the factors that hamper the growth of the market during the forecast period.

The global dermatological therapeutics market is segmented on the basis of drug class and application. Based on the drug class, the market is segmented intoanti-infectives, corticosteroids, calcineurin inhibitors, retinoids, and others. Corticosteroidsare projected to hold significant market share. Based on the application, the market is segmented intoalopecia, herpes, psoriasis, rosacea, atopic dermatitis, metastatic malignant melanoma, and others. Atopic dermatitis is projected to grow at a considerable rate during the forecast period.

Further, AbbVie Inc., Allergan PLC., Amgen Inc., ., Johnson & Johnson Services Inc., Novartis International AG,Eli Lilly & Co., and LEO Pharma A/Sare some of the prominent players operatingin the global dermatological therapeutics market. New product launches & developments, partnerships, agreements, and acquisitions are some of the growth strategies adopted by the players to sustain in the highly competitive market. For instance, in December 2019, Janssen Biotech, Inc., a Janssen Pharmaceutical Company of Johnson & Johnson, signed a definitive agreement to acquire all rights to the investigational compound bermekimab from XBiotech Inc. Bermekimab is an anti-IL-1alpha monoclonal antibody (mAb) in Phase 2 development for the treatment of atopic dermatitis and hidradenitis suppurativa.

Research Methodology

The market study of the global dermatological therapeutics market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary sources include:

  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for dermatological drugs manufacturers, pharmaceutical companies, contract manufacturers, raw material suppliers, industry associations &experts, research institutes,government organizations, regulatory bodies, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Dermatological Therapeutics Market Research and Analysis by Drug Class

2. Global Dermatological Therapeutics Market Research and Analysis by Application

The Report Covers:

  • Comprehensive research methodology of the global dermatological therapeutics market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global dermatological therapeutics market.
  • Insights about market determinants which are stimulating the global dermatological therapeutics market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of the market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Key Strategy Analysis
  • 3.2. Key Company Analysis
    • 3.2.1. Amgen Inc.
      • 3.2.1.1. Overview
      • 3.2.1.2. Financial Analysis
      • 3.2.1.3. SWOT Analysis
      • 3.2.1.4. Recent Developments
    • 3.2.2. Novartis International AG
      • 3.2.2.1. Overview
      • 3.2.2.2. Financial Analysis
      • 3.2.2.3. SWOT Analysis
      • 3.2.2.4. Recent Developments
    • 3.2.3. Abbvie Inc.
      • 3.2.3.1. Overview
      • 3.2.3.2. Financial Analysis
      • 3.2.3.3. SWOT Analysis
      • 3.2.3.4. Recent Developments
    • 3.2.4. Allergan PLC
      • 3.2.4.1. Overview
      • 3.2.4.2. Financial Analysis
      • 3.2.4.3. SWOT Analysis
      • 3.2.4.4. Recent Developments

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Dermatological Therapeutics Market by Drug Class
    • 5.1.1. Anti-infectives
    • 5.1.2. Corticosteroids
    • 5.1.3. Calcineurin Inhibitors
    • 5.1.4. Retinoids
    • 5.1.5. Others
  • 5.2. Global Dermatological Therapeutics Market by Application
    • 5.2.1. Alopecia
    • 5.2.2. Herpes
    • 5.2.3. Psoriasis
    • 5.2.4. Rosacea
    • 5.2.5. Atopic Dermatitis
    • 5.2.6. Metastatic Malignant Melanoma
    • 5.2.7. Others

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. AbbVie Inc.
  • 7.2. Aclaris Therapeutics, Inc.
  • 7.3. Allergan PLC
  • 7.4. Almirall SA
  • 7.5. Amgen Inc.
  • 7.6. Aurobindo Pharma Ltd.
  • 7.7. Bausch Health Companies Inc.
  • 7.8. Cipher Pharmaceuticals Inc.
  • 7.9. Eli Lilly & Co.
  • 7.10. Galderma SA
  • 7.11. GlaxoSmithKline PLC
  • 7.12. Glenmark Pharmaceuticals Ltd.
  • 7.13. Johnson & Johnson Services Inc.
  • 7.14. LEO Pharma A/S
  • 7.15. Novartis International AG
  • 7.16. Pfizer Inc.
  • 7.17. Sanofi SA
  • 7.18. Sun Pharmaceutical Industries Ltd.

LIST OF TABLES

  • 1. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
  • 2. GLOBAL ANTI-INFECTIVES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 3. GLOBAL CORTICOSTEROIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 4. GLOBAL CALCINEURIN INHIBITORS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 5. GLOBAL RETINOIDS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 6. GLOBAL OTHER DERMATOLOGICAL THERAPEUTICS DRUGSMARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 7. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 8. GLOBAL DERMATOLOGICAL THERAPEUTICS FOR ALOPECIA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 9. GLOBALDERMATOLOGICAL THERAPEUTICS FOR HERPES MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 10. GLOBALDERMATOLOGICAL THERAPEUTICS FOR PSORIASIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 11. GLOBALDERMATOLOGICAL THERAPEUTICS FOR ROSACEA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 12. GLOBALDERMATOLOGICAL THERAPEUTICS FOR ATOPIC DERMATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 13. GLOBALDERMATOLOGICAL THERAPEUTICS FOR METASTATIC MALIGNANT MELANOMA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 14. GLOBALDERMATOLOGICAL THERAPEUTICS FOR OTHER APPLICATIONS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
  • 15. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
  • 16. NORTH AMERICAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 17. NORTH AMERICAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
  • 18. NORTH AMERICAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 19. EUROPEAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 20. EUROPEAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
  • 21. EUROPEAN DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 22. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
  • 23. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
  • 24. ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
  • 25. REST OF THE WORLD DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY DRUG CLASS, 2018-2025 ($ MILLION)
  • 26. REST OF THE WORLD DERMATOLOGICAL THERAPEUTICS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SHARE BY DRUG CLASS, 2018 VS 2025 (%)
  • 2. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)
  • 3. GLOBAL DERMATOLOGICAL THERAPEUTICS MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
  • 4. US DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 5. CANADA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 6. UK DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 7. FRANCE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 8. GERMANY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 9. ITALY DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 10. SPAIN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 11. ROE DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 12. INDIA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 13. CHINA DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 14. JAPAN DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 15. REST OF ASIA-PACIFIC DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)
  • 16. REST OF THE WORLD DERMATOLOGICAL THERAPEUTICS MARKET SIZE, 2018-2025 ($ MILLION)